Jennison Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Jennison Associates’s Portfolio VRTX Stock Details VRTX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.74B	Buy	6,151,505 +1,089,063	+22%	+$485M	1.62%	15
2025 Q1	$2.45B	Buy	5,062,442 +744,680	+17%	+$361M	1.72%	13
2024 Q4	$1.74B	Sell	4,317,762 -1,232,624	-22%	-$496M	1.06%	22
2024 Q3	$2.58B	Buy	5,550,386 +851,054	+18%	+$396M	1.6%	14
2024 Q2	$2.2B	Sell	4,699,332 -83,042	-2%	-$38.9M	1.41%	18
2024 Q1	$2B	Buy	4,782,374 +837,461	+21%	+$350M	1.34%	18
2023 Q4	$1.61B	Buy	3,944,913 +147,248	+4%	+$59.9M	1.2%	26
2023 Q3	$1.32B	Sell	3,797,665 -7,976	-0.2%	-$2.77M	1.12%	26
2023 Q2	$1.34B	Sell	3,805,641 -774,160	-17%	-$272M	1.1%	26
2023 Q1	$1.44B	Sell	4,579,801 -535,739	-10%	-$169M	1.32%	20
2022 Q4	$1.48B	Buy	5,115,540 +359,719	+8%	+$104M	1.5%	17
2022 Q3	$1.38B	Buy	4,755,821 +2,983,253	+168%	+$864M	1.37%	18
2022 Q2	$499M	Buy	1,772,568 +1,422,478	+406%	+$401M	0.5%	42
2022 Q1	$91.4M	Sell	350,090 -433,299	-55%	-$113M	0.07%	131
2021 Q4	$172M	Sell	783,389 -45,970	-6%	-$10.1M	0.11%	85
2021 Q3	$150M	Buy	829,359 +37,531	+5%	+$6.81M	0.1%	91
2021 Q2	$160M	Buy	791,828 +76,039	+11%	+$15.3M	0.11%	87
2021 Q1	$154M	Sell	715,789 -3,033,565	-81%	-$652M	0.11%	86
2020 Q4	$886M	Buy	3,749,354 +140,270	+4%	+$33.2M	0.63%	41
2020 Q3	$982M	Sell	3,609,084 -809,397	-18%	-$220M	0.79%	39
2020 Q2	$1.28B	Buy	4,418,481 +56,726	+1%	+$16.5M	1.16%	24
2020 Q1	$1.04B	Buy	4,361,755 +790,506	+22%	+$188M	1.26%	22
2019 Q4	$782M	Sell	3,571,249 -2,406,492	-40%	-$527M	0.79%	37
2019 Q3	$1.01B	Sell	5,977,741 -366,718	-6%	-$62.1M	1.07%	29
2019 Q2	$1.16B	Sell	6,344,459 -455,977	-7%	-$83.6M	1.15%	26
2019 Q1	$1.25B	Sell	6,800,436 -141,185	-2%	-$26M	1.24%	24
2018 Q4	$1.15B	Buy	6,941,621 +739,128	+12%	+$122M	1.29%	23
2018 Q3	$1.2B	Buy	6,202,493 +1,139,486	+23%	+$220M	1.1%	27
2018 Q2	$861M	Sell	5,063,007 -1,712,321	-25%	-$291M	0.84%	37
2018 Q1	$1.1B	Buy	6,775,328 +1,237,421	+22%	+$202M	1.1%	27
2017 Q4	$830M	Sell	5,537,907 -479,859	-8%	-$71.9M	0.82%	42
2017 Q3	$915M	Buy	6,017,766 +962,644	+19%	+$146M	0.94%	29
2017 Q2	$651M	Buy	5,055,122 +3,626,368	+254%	+$467M	0.69%	40
2017 Q1	$156M	Buy	1,428,754 +125,744	+10%	+$13.8M	0.17%	89
2016 Q4	$96M	Sell	1,303,010 -3,877,751	-75%	-$286M	0.11%	159
2016 Q3	$452M	Buy	5,180,761 +2,205,961	+74%	+$192M	0.49%	49
2016 Q2	$256M	Buy	2,974,800 +1,920,658	+182%	+$165M	0.28%	65
2016 Q1	$83.8M	Sell	1,054,142 -1,029,650	-49%	-$81.8M	0.09%	194
2015 Q4	$262M	Sell	2,083,792 -250,915	-11%	-$31.6M	0.26%	71
2015 Q3	$243M	Sell	2,334,707 -2,770,547	-54%	-$289M	0.25%	78
2015 Q2	$630M	Sell	5,105,254 -1,443,237	-22%	-$178M	0.58%	49
2015 Q1	$773M	Sell	6,548,491 -157,255	-2%	-$18.6M	0.71%	43
2014 Q4	$797M	Sell	6,705,746 -3,743,006	-36%	-$445M	0.74%	43
2014 Q3	$1.17B	Sell	10,448,752 -1,416,257	-12%	-$159M	1.09%	23
2014 Q2	$1.12B	Sell	11,865,009 -739,038	-6%	-$70M	1.03%	26
2014 Q1	$891M	Sell	12,604,047 -870,831	-6%	-$61.6M	0.85%	35
2013 Q4	$1B	Sell	13,474,878 -469,415	-3%	-$34.9M	0.98%	25
2013 Q3	$1.06B	Sell	13,944,293 -3,254,728	-19%	-$247M	1.11%	17
2013 Q2	$1.37B	Buy	+17,199,021	New	+$1.37B	1.55%	8